BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26658478)

  • 1. Critical roles for murine Reck in the regulation of vascular patterning and stabilization.
    de Almeida GM; Yamamoto M; Morioka Y; Ogawa S; Matsuzaki T; Noda M
    Sci Rep; 2015 Dec; 5():17860. PubMed ID: 26658478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in mice.
    Chandana EP; Maeda Y; Ueda A; Kiyonari H; Oshima N; Yamamoto M; Kondo S; Oh J; Takahashi R; Yoshida Y; Kawashima S; Alexander DB; Kitayama H; Takahashi C; Tabata Y; Matsuzaki T; Noda M
    BMC Dev Biol; 2010 Aug; 10():84. PubMed ID: 20691046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Hypothesis for the Role of RECK in Angiogenesis.
    Gutiérrez J; Droppelmann CA; Salsoso R; Westermeier F; Toledo F; Salomon C; Sanhueza C; Pardo F; Leiva A; Sobrevia L
    Curr Vasc Pharmacol; 2016; 14(1):106-15. PubMed ID: 26463982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis.
    Oh J; Takahashi R; Kondo S; Mizoguchi A; Adachi E; Sasahara RM; Nishimura S; Imamura Y; Kitayama H; Alexander DB; Ide C; Horan TP; Arakawa T; Yoshida H; Nishikawa S; Itoh Y; Seiki M; Itohara S; Takahashi C; Noda M
    Cell; 2001 Dec; 107(6):789-800. PubMed ID: 11747814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling.
    Noda M; Oh J; Takahashi R; Kondo S; Kitayama H; Takahashi C
    Cancer Metastasis Rev; 2003; 22(2-3):167-75. PubMed ID: 12784995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of a mouse line carrying Reck-CreERT2 knock-in allele.
    Matsuzaki T; Wang H; Imamura Y; Kondo S; Ogawa S; Noda M
    Genesis; 2018 Apr; 56(4):e23099. PubMed ID: 29508517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RECK gene and biological malignancy--its significance in angiogenesis and inhibition of matrix metalloproteinases.
    Alexius-Lindgren M; Andersson E; Lindstedt I; Engström W
    Anticancer Res; 2014 Aug; 34(8):3867-73. PubMed ID: 25075007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RECK-Mediated β1-Integrin Regulation by TGF-β1 Is Critical for Wound Contraction in Mice.
    Gutiérrez J; Droppelmann CA; Contreras O; Takahashi C; Brandan E
    PLoS One; 2015; 10(8):e0135005. PubMed ID: 26247610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reck enables cerebrovascular development by promoting canonical Wnt signaling.
    Ulrich F; Carretero-Ortega J; Menéndez J; Narvaez C; Sun B; Lancaster E; Pershad V; Trzaska S; Véliz E; Kamei M; Prendergast A; Kidd KR; Shaw KM; Castranova DA; Pham VN; Lo BD; Martin BL; Raible DW; Weinstein BM; Torres-Vázquez J
    Development; 2016 Jan; 143(1):147-59. PubMed ID: 26657775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RECK forms cowbell-shaped dimers and inhibits matrix metalloproteinase-catalyzed cleavage of fibronectin.
    Omura A; Matsuzaki T; Mio K; Ogura T; Yamamoto M; Fujita A; Okawa K; Kitayama H; Takahashi C; Sato C; Noda M
    J Biol Chem; 2009 Feb; 284(6):3461-9. PubMed ID: 19022775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reck and Gpr124 Are Essential Receptor Cofactors for Wnt7a/Wnt7b-Specific Signaling in Mammalian CNS Angiogenesis and Blood-Brain Barrier Regulation.
    Cho C; Smallwood PM; Nathans J
    Neuron; 2017 Aug; 95(5):1056-1073.e5. PubMed ID: 28803732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ß1-integrin-dependent function of RECK in physiologic and tumor angiogenesis.
    Miki T; Shamma A; Kitajima S; Takegami Y; Noda M; Nakashima Y; Watanabe K; Takahashi C
    Mol Cancer Res; 2010 May; 8(5):665-76. PubMed ID: 20407016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the SKP2-p27(KIP1) pathway in suppression of cancer cell proliferation by RECK.
    Yoshida Y; Ninomiya K; Hamada H; Noda M
    Oncogene; 2012 Sep; 31(37):4128-38. PubMed ID: 22158033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual effects of the membrane-anchored MMP regulator RECK on chondrogenic differentiation of ATDC5 cells.
    Kondo S; Shukunami C; Morioka Y; Matsumoto N; Takahashi R; Oh J; Atsumi T; Umezawa A; Kudo A; Kitayama H; Hiraki Y; Noda M
    J Cell Sci; 2007 Mar; 120(Pt 5):849-57. PubMed ID: 17298979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversion-inducing-cysteine-rich protein with Kazal motif is involved in intimal hyperplasia in carotid arteries: a new insight in the prevention of restenosis after vascular angioplasty.
    Liu J; Chi D; Lu H; Zhang T; Yamakawa T
    Ann Vasc Surg; 2015 Aug; 29(6):1293-9. PubMed ID: 26004948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.
    Hong KJ; Wu DC; Cheng KH; Chen LT; Hung WC
    J Cell Physiol; 2014 Feb; 229(2):191-201. PubMed ID: 23881612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Density- and serum-dependent regulation of the Reck tumor suppressor in mouse embryo fibroblasts.
    Hatta M; Matsuzaki T; Morioka Y; Yoshida Y; Noda M
    Cell Signal; 2009 Dec; 21(12):1885-93. PubMed ID: 19720143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The membrane-anchored metalloproteinase regulator RECK stabilizes focal adhesions and anterior-posterior polarity in fibroblasts.
    Morioka Y; Monypenny J; Matsuzaki T; Shi S; Alexander DB; Kitayama H; Noda M
    Oncogene; 2009 Mar; 28(11):1454-64. PubMed ID: 19169281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling.
    Kitajima S; Miki T; Takegami Y; Kido Y; Noda M; Hara E; Shamma A; Takahashi C
    Oncogene; 2011 Feb; 30(6):737-50. PubMed ID: 20890302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.